Buspirone Hydrochloride Tablet
Product Images NDC 51655-015

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Buspirone Hydrochloride (NDC 51655-015). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

51655-015-52 (51655 015 52)

Buspirone Hydrochloride 15 mg oral tablets packaging label showing 30 tablets per bottle. The label includes the drug name, strength, quantity, Rx only designation, lot number NW34250001, and expiration date 06/2016. Manufacturer and distributor information includes Pliva Hrvatska Zagreb, Croatia and Teva Pharmaceuticals, Seltersville, PA. Repackaged by Northwind Pharmaceuticals, Indianapolis, IN. Storage instructions and reference to the medication guide on the FDA website are also visible.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.